--- title: Rapid Tech Transfer for Microbial Biologics | AES Biologics description: Accelerate your microbial biologics development with AES Biologics' efficient tech transfer, ensuring quick, reliable pathways to scale-up and IND readiness. image: https://www.aesbiologics.com/hubfs/AdobeStock_1822077417.jpeg --- [Skip to content](https://www.aesbiologics.com/tech-transfer#main-content) ![AES Biologics-stacked logo-2026-teal](https://www.aesbiologics.com/hs-fs/hubfs/AES%20Biologics-stacked%20logo-2026-teal.png?width=849&height=785&name=AES%20Biologics-stacked%20logo-2026-teal.png)Homepage - [About](https://www.aesbiologics.com/about-us?hsLang=en) - [Capabilities](https://www.aesbiologics.com/capabilities?hsLang=en) - [Applications](https://www.aesbiologics.com/applications?hsLang=en) - [Tech Transfer](https://www.aesbiologics.com/tech-transfer) - [Facility](https://www.aesbiologics.com/facility?hsLang=en) Get started - [About](https://www.aesbiologics.com/about-us?hsLang=en) - [Capabilities](https://www.aesbiologics.com/capabilities?hsLang=en) - [Applications](https://www.aesbiologics.com/applications?hsLang=en) - [Tech Transfer](https://www.aesbiologics.com/tech-transfer) - [Facility](https://www.aesbiologics.com/facility?hsLang=en) Get started # Rapid, Reliable Tech Transfer for Microbial Biologics ### AES Biologics accelerates tech transfer for programs at any stage, helping innovators move confidently toward development, scale-up, and IND readiness with speed, clarity, and scientific rigor [Request a Consultation](https://www.aesbiologics.com/contact-us?hsLang=en) [Explore our Capabilities](https://www.aesbiologics.com/capabilities?hsLang=en) ## Why Tech Transfer Matters More Than ![Technicians in full cleanroom PPE operating automated equipment on a sterile biologics manufacturing line, with rows of filled vials moving along a conveyor in a GMP production facility.](https://www.aesbiologics.com/hs-fs/hubfs/AdobeStock_728058209-1.jpeg?width=2000&height=1120&name=AdobeStock_728058209-1.jpeg "Technicians in full cleanroom PPE operating automated equipment on a sterile biologics manufacturing line, with rows of filled vials moving along a conveyor in a GMP production facility.") Early-stage and established biologics companies face the same core pressures: - You need to reduce development risk - You need predictable timelines driven by right-first-time (RTF) execution - You need a partner to translate complex science into manufacturable, scalable processes. Delays in tech transfer are a leading cause of budget overruns and stalled IND submissions. AES Biologics applies an RTF mindset to tech transfer—compressing timelines, minimizing rework, and maintaining transparency so programs move forward with confidence, no matter the starting point. ## Our Philosophy: Tech Transfer as A Strategy At AES Biologics, tech transfer is more than a data exchange. It’s a structured, science-driven process that ensures your molecule is ready for development, scale-up, and GMP alignment. Our team applies engineering discipline, analytical insight, and regulatory alignment from day one, no after if your program begins with a genetic sequence, an existing strain, or a fully developed technical package. This results in a smoother transition into development and provides a stronger foundation for future manufacturing. ## What Makes AES Tech Transfer Different The AES Biologics facility is sized and configured to support early-stage and first-in-human programs while maintaining the rigor required for clinical manufacturing. ### Facility Fit without the Bottlenecks AES performs facility-fit evaluations to help you understand how your bioprocess aligns with our in-house capabilities and whether any adjustments are needed. ### Capital-Efficient Development Our engineering-first approach improves yield, stability, and process robustness while reducing avoidable costs associated with rework or poor process design. ### Engineering + Automation from the Beginning We apply automation, digital systems, and process control early in development to improve consistency and accelerate future scale-up. Creating a more predictable, data-driven path toward GMP production ### Regulatory & Documentation Alignment We generate development reports aligned with ICH QbD expectations so you can incorporate them into regulatory filings. Minimizing back-and-forth during IND preparation and streamlining clinical readiness ## What We Evaluate During Tech Transfer We focus on the factors that determine whether a program can move forward efficiently and successfully: - Strain or cell line suitability - Process and scale fit - Analytical completeness - Engineering and automation requirements - Documentation Quality - Risk factors - Opportunities to improve stability, yield, or reproducibility This evaluation is high-level, collaborative, and designed to support a seamless transition into development work.   ![Engineer evaluating data on screen in GMP facility](https://www.aesbiologics.com/hs-fs/hubfs/AdobeStock_1822077417.jpeg?width=2000&height=1120&name=AdobeStock_1822077417.jpeg "Engineer evaluating data on screen in GMP facility") ## What our Tech Transfer Process Looks Like Step 1: Scientific & Process Assessment We review available data to understand the molecule, its behaviour, and the path to manufacturability Step 2: Engineering Digital Mapping Our team identifies automation needs, process controls, scale considerations, and data requirements to enable development Step 3. Development Execution Depending on program maturity, this could include strain development, optimization, or pilot-scale work, with an emphasis on speed and consistency. Step 4: IND-Ready Documentation We deliver well-organized, regulatory-aligned documentation to support IND submissions and future manufacturing stages ## Who We Support AES Biologics partners with companies across a broad spectrum of development maturity. We work with early research teams preparing to translate their first molecule into development, to established biotech organizations advancing new programs or transitioning existing ones. ### Our Ideal Partners value - Clear communication - Predictable timelines - Strong Scientific and engineering collaboration - High-quality development supporting regulatory success If your molecule requires thoughtful, efficient, and technically rigorous transfer into a capable development environment, we can help. ![man smiling with teeth holding a tablet wearing a grey suit against a teal background](https://www.aesbiologics.com/hs-fs/hubfs/Contact%20Us%20Page%20form-2.png?width=338&height=600&name=Contact%20Us%20Page%20form-2.png "man smiling with teeth holding a tablet wearing a grey suit against a teal background") ## What success looks like #### Faster movement from concept to development ### Few delays and schedule surprises ### Strong scientific understanding of the molecule ### Clear, IND-ready documentation ### A reliable path toward scale-up and GMP readiness ## Why AES Biologics? Whether you’re preparing your first development programs or advancing a mature process, we provide a tech transfer approach that positions you for success today and tomorrow. ### Fast, reliable, and transparent ### Built on engineering & scientific depth ### Designed for capital efficiency and reduced risk ### Supported by automation, data, and quality systems ### Ready to scale as your program grows ## Start Your Tech Transfer with Confidence Whether you’re preparing for development, scale-up, or IND submission, AES Biologics provides a disciplined, right-first-time approach that keeps programs moving forward. Let’s discuss your timeline, your data, and your next milestone. [Request a Consultation Today](https://www.aesbiologics.com/contact-us?hsLang=en) [![AES Biologics-stacked logo-2026-teal](https://www.aesbiologics.com/hs-fs/hubfs/AES%20Biologics-stacked%20logo-2026-teal.png?width=100&height=93&name=AES%20Biologics-stacked%20logo-2026-teal.png "AES Biologics-stacked logo-2026-teal")](https://www.aesbiologics.com/?hsLang=en) - [About](https://www.aesbiologics.com/about-us?hsLang=en) - [Capabilities](https://www.aesbiologics.com/capabilities?hsLang=en) - [Applications](https://www.aesbiologics.com/applications?hsLang=en) - [Tech Transfer](https://www.aesbiologics.com/tech-transfer) - [Facility](https://www.aesbiologics.com/facility?hsLang=en) --- Privacy Policy · Legal · © 2026. All rights reserved.